Login / Signup

Treating latent autoimmune diabetes in adults in the era of cardiovascular outcomes trials: Old dog should learn new tricks.

Theocharis KoufakisPrashanth VasKalliopi Kotsa
Published in: Diabetic medicine : a journal of the British Diabetic Association (2021)
Individualisation, preservation of beta-cell mass and function and cardiorenal protection are the new challenges in LADA therapy.
Keyphrases
  • type diabetes
  • cell therapy
  • single cell
  • cardiovascular disease
  • multiple sclerosis
  • glycemic control
  • stem cells
  • drug induced
  • metabolic syndrome
  • bone marrow
  • skeletal muscle
  • weight loss